UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway Journal article
Teng, Yong Jie, Deng, Zhe, Ouyang, Zhao Guang, Zhou, Qing, Mei, Si, Fan, Xing Xing, Wu, Yong Rong, Long, Hong Ping, Fang, Le Yao, Yin, Dong Liang, Zhang, Bo Yu, Guo, Yin Mei, Zhu, Wen Hao, Huang, Zhen, Zheng, Piao, Ning, Di Min, Tian, Xue Fei. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway[J]. World Journal of Gastrointestinal Oncology, 2022, 14(4), 872-886.
Authors:  Teng, Yong Jie;  Deng, Zhe;  Ouyang, Zhao Guang;  Zhou, Qing;  Mei, Si; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:2.5/2.8 | Submit date:2023/01/30
Antitumour  Apoptosis  Hepatocellular Carcinoma  Phosphoinositide 3-kinase/protein Kinase-b/mechanistic Target Of Rapamycin Pathway  Xihuang Pills  
Amino acids regulate energy utilization through mammalian target of rapamycin complex 1 and adenosine monophosphate activated protein kinase pathway in porcine enterocytes Journal article
Xiao, Hao, Zha, Cuifang, Shao, Fangyuan, Wang, Li, Tan, Bi'e. Amino acids regulate energy utilization through mammalian target of rapamycin complex 1 and adenosine monophosphate activated protein kinase pathway in porcine enterocytes[J]. Animal Nutrition, 2020, 6(1), 98-106.
Authors:  Xiao, Hao;  Zha, Cuifang;  Shao, Fangyuan;  Wang, Li;  Tan, Bi'e
Favorite | TC[WOS]:8 TC[Scopus]:10 | Submit date:2021/12/06
Adenosine Monophosphate Activated Protein Kinase  Amino Acids  Energy Utilization  Mammalian Target Of Rapamycin  Mitochondrial Respiration  
Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice Journal article
Yin Dou, Jiawei Guo, Yue Chen, Songling Han, Xiaoqiu Xu, Qing Shi, Yi Jia, Ya Liu, Youcai Deng, Ruibing Wang, Xiaohui Li, Jianxiang Zhang. Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in mice[J]. Journal of Controlled Release, 2016, 235, 48-62.
Authors:  Yin Dou;  Jiawei Guo;  Yue Chen;  Songling Han;  Xiaoqiu Xu; et al.
Favorite | TC[WOS]:40 TC[Scopus]:43  IF:10.5/10.6 | Submit date:2018/11/06
Atherosclerosis  Cyclodextrin  Mtor  Nanomedicine  Rapamycin  Sustained Delivery  
A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition Journal article
Song J.-X., Sun Y.-R., Peluso I., Zeng Y., Yu X., Lu J.-H., Xu Z., Wang M.-Z., Liu L.-F., Huang Y.-Y., Chen L.-L., Durairajan S.S.K., Zhang H.-J., Zhou B., Zhang H.-Q., Lu A., Ballabio A., Medina D.L., Guo Z., Li M.. A novel curcumin analog binds to and activates TFEB in vitro and in vivo independent of MTOR inhibition[J]. Autophagy, 2016, 12(8), 1372-1389.
Authors:  Song J.-X.;  Sun Y.-R.;  Peluso I.;  Zeng Y.;  Yu X.; et al.
Favorite | TC[WOS]:135 TC[Scopus]:148 | Submit date:2019/01/15
Autophagy  Curcumin Analogs  Lysosomal Biogenesis  Mechanistic Target Of Rapamycin  Transcription Factor Eb  
Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension Journal article
Tang H., Chen J., Fraidenburg D.R., Song S., Sysol J.R., Drennan A.R., Offermanns S., Ye R.D., Bonini M.G., Minshall R.D., Garcia J.G.N., Machado R.F., Makino A., Yuan J.X.-J.. Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension[J]. American Journal of Physiology - Lung Cellular and Molecular Physiology, 2015, 308(2), L208-L220.
Authors:  Tang H.;  Chen J.;  Fraidenburg D.R.;  Song S.;  Sysol J.R.; et al.
Favorite | TC[WOS]:77 TC[Scopus]:78 | Submit date:2018/11/07
Akt/mammalian Target Of Rapamycin Signaling  Hypoxia  Pulmonary Vascular Remodeling  Smooth Muscle Cell Proliferation  
Autophagy in ageing and ageing-associated diseases Journal article
He, Li-qiang, Lu, Jia-hong, Yue, Zhen-yu. Autophagy in ageing and ageing-associated diseases[J]. Acta Pharmacologica Sinica, 2013, 34(5), 605-611.
Authors:  He, Li-qiang;  Lu, Jia-hong;  Yue, Zhen-yu
Favorite | TC[WOS]:82 TC[Scopus]:86  IF:6.9/7.6 | Submit date:2019/01/19
Autophagy  Neurodegenerative Diseases  Sirtuin 1  P53  Rapamycin  Resveratrol  Spermidine  Ageing  Ageing-associated Diseases  Cancer  
Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. International Immunopharmacology. Journal article
Kopf, H., Rosa, G., Howard, O., Chen, X.. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. International Immunopharmacology.[J]. International Immunopharmacology, 2007, 1819-1824.
Authors:  Kopf, H.;  Rosa, G.;  Howard, O.;  Chen, X.
Favorite |   IF:4.8/5.0 | Submit date:2022/08/30
rapamycin  CD4+CD25+FoxP3+ T regulatory cells  Th17 cells  
Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells Journal article
Kopf H., de la Rosa G.M., Howard O.M.Z., Chen X.. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells[J]. International Immunopharmacology, 2007, 7(13), 1819-1824.
Authors:  Kopf H.;  de la Rosa G.M.;  Howard O.M.Z.;  Chen X.
Favorite | TC[WOS]:219 TC[Scopus]:224  IF:4.8/5.0 | Submit date:2018/11/06
cd4+cd25+foxp3+ t Regulatory Cells  Rapamycin  Th17 Cells  
Rapamycin inhibits differentiation of Th17 cells and promotesgeneration of FoxP3+ T regulatory cells Journal article
Heather Kopf, Gonzalo M. de la Rosa, O.M.Zack Howard, Xin Chen. Rapamycin inhibits differentiation of Th17 cells and promotesgeneration of FoxP3+ T regulatory cells[J]. International Immunopharmacology, 2007, 7(13), 1819-1824.
Authors:  Heather Kopf;  Gonzalo M. de la Rosa;  O.M.Zack Howard;  Xin Chen
Favorite | TC[WOS]:219 TC[Scopus]:223  IF:4.8/5.0 | Submit date:2020/01/07
Rapamycin  cd4+cd25+foxp3+ t Regulatory Cells  Th17 Cells